Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
We outline common circumstances where index funds may be preferable to ETFs, including buy-and-hold strategies and simplicity.
25,141 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
DigitalOcean beats Q4 2025 expectations as AI-driven ARR surges to $120 million, lifting revenue to $242 million and ...
Young shoppers are driving a tangible-media surge, lifting vinyl and print book sales in the U.S. and U.K. while rede...
Axon Enterprises indicates a rapid pivot from hardware to AI-driven software and services as bookings climb. The shif...
IonQ posted quarterly results that beat expectations, triggering a notable after-hours rally. Analysts warn the stock...
NVIDIA shattered expectations with a historic earnings beat, but its stock moved lower as traders reassessed forward ...
WTRG just released its quarterly earnings, and the market is parsing revenue growth, margins, and forward guidance. T...
As markets swing and rates climb, investors increasingly turn to high-yield REITs for reliable cash flow. This report...
Two decades after a flopped acting debut, David Ellison’s Skydance is moving from indie financier to potential indust...
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
As Archer Aviation moves toward broader commercial programs, investors need a clear view of 2025 earnings drivers. Th...
A veteran's take on holding (onon) 2025 earnings: what to watch, where margins could move, and how to plan for the Q4...